Respiratory News and Research

RSS

Watson Pharmaceuticals announces limited recall of Fentanyl transdermal patches

Watson Pharmaceuticals, Inc. has announced that one lot of 75 mcg/hr Fentanyl Transdermal System patches sold in the United States is being voluntarily recalled from wholesalers and pharmacies.

10 Aug 2008

Wheezing after early-life antibiotics: Blame the underlying chest infection more than the antibiotics

Children who are given antibiotics in their first three months often wheeze at 15 months of age. However, this wheezing is probably more due to the presence of chest infections than to the use of antibiotics.

6 Aug 2008

FDA approves seasons influenza vaccines

The U.S. Food and Drug Administration (FDA) today announced that it has approved this year's seasonal influenza vaccines that include new strains of the virus likely to cause flu in the United States during the 2008-2009 season.

5 Aug 2008

Immune system protein accurate predictor of survival in pediatric septic shock

About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours of being admitted to the hospital for septic shock can predict survival in children, yielding a powerful tool for diagnostics and clinical trials of new septic shock therapies, according to a research team led by Cincinnati Children's Hospital Medical Center in the Aug. 1 American Journal of Respiratory and Critical Care Medicine.

4 Aug 2008

Sleep apnea is an independent risk factor for all-cause mortality

Moderate to severe obstructive sleep apnea (OSA) is an independent risk factor for all-cause mortality, according to a study in the August 1 issue of the journal Sleep.

4 Aug 2008

Current tuberculosis treatment regimens need to updated

The standard regimens to treat tuberculosis (TB) are inadequate in countries with high rates of multi-drug resistant (MDR) TB. In countries with high rates of MDR-TB, patients are nearly twice as likely to fail their initial treatment than those in countries with low rates, according to a new analysis of World Health Organization (WHO) data. This finding suggests strongly that current TB treatment regimens need to updated and revised to address the shifting landscape of public health in the face of MDR-TB.

3 Aug 2008

Genetic defect in skin cells leads to neurodermatitis, hay fever and asthma

New knowledge points to the fact that a genetically induced lack of filaggrin, a key protein of the skin barrier, plays a decisive role in the origin of allergies.

3 Aug 2008

Mother support maximizes life-saving benefits of breastfeeding in all countries of the Americas and the World

Exclusive breastfeeding for the first six months of a child's life is the best and most cost-effective intervention to provide newborns with the nutrients they need, and to improve infant and children survival rates.

31 Jul 2008

Alcohol linked to increased risk of perennial allergic rhinitis

There is a link between alcohol consumption and increased risk of perennial allergic rhinitis, according to a recent Danish study of 5,870 young adult women.

29 Jul 2008

Premature babies at risk of lung problems later on

According to Australian researchers some premature babies may have a higher risk of developing emphysema and other lung problems later on.

29 Jul 2008

Medical errors costing $1.5 billion annually

Potentially preventable medical errors that occur during or after surgery may cost employers nearly $1.5 billion a year, according to new estimates by HHS' Agency for Healthcare Research and Quality.

28 Jul 2008

Roche acquires Mirus to advance RNAi delivery research

Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.

22 Jul 2008

Teva Pharmaceutical Industries to buy Barr Pharmaceuticals

Teva Pharmaceutical Industries Ltd and Barr Pharmaceuticals, Inc. announced today that they have signed a definitive agreement under which Teva will acquire Barr, the fourth largest generic drug company worldwide.

18 Jul 2008

Low-sodium advice for asthmatics should be taken with a pinch of salt

Following a low-sodium diet does not appear to have any appreciable impact on asthma control, according to new research.

15 Jul 2008

Allergy to road traffic

Allergic diseases appear more often in children who grow up near busy roads. This is the result of a study of several thousand children, now published in the American Journal of Respiratory and Critical Care Medicine.

14 Jul 2008

How are homeopathic products used in childhood?

Despite recent questions concerning the efficacy of homeopathic medicine, it continues to be one of the most popular forms of Complementary and Alternative Medicine (CAM) in use today. Jackie Bishop of the Children of the 90s study looks at the use of homeopathic products in the early years of life.

13 Jul 2008

46 percent of Americans show biologic exposure to the deadly toxins found in cigarettes

A new report issued today by the Centers for Disease Control (CDC) exemplifies the need for nonsmoking Americans to be better protected against exposure to secondhand smoke. The report finds that 46 percent of Americans show biologic exposure to the deadly toxins found in cigarettes. Even more startling are the millions of children this statistic includes.

10 Jul 2008

New safety measures for soil fumigant pesticides

New safety measures for soil fumigant pesticides will increase protections for agricultural workers and bystanders - people who live, work, or otherwise spend time near fields that are fumigated. For the soil fumigants methyl bromide, chloropicrin, dazomet, metam sodium, and metam potassium, EPA will require a suite of new mitigation measures that will work together to protect human health.

10 Jul 2008

Hendra virus puts the horse world on high alert again

An outbreak of Hendra virus in Queensland is causing concern among the equine community.

10 Jul 2008

Research sheds light on the molecular basis of SIDS

Sudden Infant Death Syndrome (SIDS) is a condition that unexpectedly and unexplainably takes the lives of seemingly healthy babies aged between a month and a year.

3 Jul 2008